Vietnam Journal of Diabetes and Endocrinology
Physical activity levels and some factors associated with sarcopenia among older diabetic patients
Cross-sectional study of 304 peopleSarcopenia
Papers on HbA1c <7%
106 papers8 new in 30 days
Wednesday, April 29
Monday, March 30
Primary Care Diabetes
Clinical trends in Catalonia's Primary Care Setting (2018-2023) in Elderly (≥75 years) and Frail Adults with Type 2 Diabetes
Cross-sectional study of 250,571 peopleType 2 diabetes
Genome Medicine
Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists
Cohort study of 1,119 peopleGLP-1 receptor agonists
Thursday, March 26
International Journal of Medical Informatics
Digital twin technologies for supporting self-care in adults with diet-related chronic conditions: a systematic review
Systematic review of studies in peopleInterventions
Wednesday, March 25
Diabetes, Obesity & Metabolism
Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Type 2 Diabetes: Real-World Evidence From the REALISED Study
Cohort study of 195 peopleSemaglutide
Monday, February 2
Saturday, January 3
GSA 2025 Abstract
Prediction of Sarcopenia Onset in Older Adults with Diabetes using Urinary Titin Levels: A Japanese Cohort Study
Cohort study of 287 peopleSarcopenia
Friday, December 26
AAIC 2025 Abstract
Investigating the Association of Frailty Score and Diabetes with Relative Brain Age : Insights from the UK Biobank
Cohort study in peopleType 2 diabetes
Monday, December 15
Thursday, December 4
medRxiv
Comorbidities, geriatric syndromes, and glycaemic control among older patients with diabetes: a multi-centre study in Vietnam
Preprint: cross-sectional study of 576 peopleType 2 diabetes
Monday, November 24
World Journal of Diabetes
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial
Study of 323 peopleType 2 diabetes
Friday, November 7
The American Journal of Medicine
Early glycemic control and subsequent risk of incident dementia among new metformin users
Cohort study of 46,332 peopleDementia
Monday, November 3
AHA Scientific Sessions 2025 Abstract
Impact of GLP-1 Analog Use on Clinical Outcomes Following Bariatric Surgery: A Propensity-Matched Retrospective Cohort Study
Cohort study of 18,017 peopleInterventions
AHA Scientific Sessions 2025 Abstract
Hyperglycemia and the Longitudinal Progression of Carotid Artery Stiffness Mechanisms: The Multi-Ethnic Study of Atherosclerosis
Cohort study of 2,728 peopleMechanisms
Friday, October 31
Internal Medicine Journal
Metabolic benefits of therapeutic exercise in older adults with type 2 diabetes mellitus and multimorbidity: a retrospective cohort study
Cohort study of 43 peopleExercise
Monday, August 25
Diabetes Care
Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study
Cohort study of 444 peopleSarcopenia
Thursday, July 10
Saturday, June 21
ADA Scientific Sessions 2025 Abstract
Effect of Type 2 Diabetes Characteristics on Semaglutide Treatment in People with Type 2 Diabetes and Peripheral Artery Disease—A Post Hoc Analysis of the STRIDE Trial
Randomized trial in 792 peopleSemaglutide
Thursday, June 19
Diabetes, Obesity & Metabolism
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes
Computational studyTirzepatide
Friday, June 13
ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of RAY1225 Once Every Two Weeks in Chinese Adults with Type 2 Diabetes (SHINING-1)
Randomized trial in 132 peopleType 2 diabetes
ADA Scientific Sessions 2025 Abstract
Comparative Glycemic Effectiveness of Four Second-Line Glucose-Lowering Medications in Type 2 Diabetes Mellitus
Cohort study of 11,148 peopleType 2 diabetes
ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of Bofanglutide (GZR18), a Biweekly GLP-1RA, Compared with Semaglutide in Chinese Patients with T2D
Randomized trial in 272 peopleType 2 diabetes
ADA Scientific Sessions 2025 Abstract
Real-World Impact of Oral Semaglutide (SEMA) vs. DPP-4 Inhibitors on Weight, BMI, and HbA1c Outcomes in Type 2 Diabetes (T2D)—An Observational Study (PAUSE)
Cohort study of 486 peopleSemaglutide
ADA Scientific Sessions 2025 Abstract
Integrated Diabetes Care Improves Metabolic Outcomes and Promotes Utilization of Incretin Analogs and Sodium–Glucose Cotransporter Type 2 Inhibitors in Patients with Serious Mental Illness
Non-randomized trial in 68 peopleSGLT2 inhibitors
Saturday, April 12
BMC Oral Health
Influencing factors of oral frailty in elderly patients with type 2 diabetes in China: a cross-sectional study based on the integral model of frailty
Cross-sectional study of 431 peopleType 2 diabetes
Friday, April 4
Diabetes, Obesity & Metabolism
Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States
Cohort study of 2,247 peopleTirzepatide
Friday, January 10
Diabetes Therapy
Characteristics and Dosing Patterns of Tirzepatide Users with Type 2 Diabetes in the United States
Cohort study of 15,665 peopleType 2 diabetes
Diabetes, Obesity & Metabolism
Real-world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide (SEMA-elderly)
Cohort study of 101 peopleSemaglutide
Saturday, July 27
Diabetes Research and Clinical Practice
Disability and Quality of Life Measures in older frail and prefrail people with type 2 diabetes. The MIDFRAIL-Study
Randomized trial in 843 peopleDisability
Monday, February 12
Diabetes, Metabolic Syndrome and Obesity
The Effect of Tirzepatide on Weight, Lipid Metabolism and Blood Pressure in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Meta-analysis of randomized trialsTirzepatide